In addition, it has been shown that rapamycin (an mTOR inhibitor) prevents both cell adhesion and F-actin reorganization induced by insulin-like growth factor 1 (IGF-1) in different tumor cell lines (Liu et al., 2008; Chen et al., 2015). The gene discussed is IGF1; the disease is neoplasm.